As per DelveInsight’s assessment, the global transcatheter aortic valve replacement market was valued at USD 3.23 billion in 2021 and growing at a CAGR of 15.41% during the forecast period (2022-2027); it is anticipated to reach USD 7.64 billion by 2027. Some of the key factors, such as the increasing prevalence of aortic stenosis disorder, rise in cardiovascular disorders, increasing demand for TAVR procedures, increasing prevalence of aortic regurgitation, and the technological advancements in the device’s development, are anticipated to drive the market growth in the coming years.
The leading MedTech companies in the global transcatheter aortic valve replacement devices market include Medtronic, Edwards Lifesciences Corporation, Boston Scientific Corporation, Meril Life Sciences, Abbott, JenaValve Technology, Inc., Bracco SpA, Transcatheter Technologies GmbH, Braile Biomedica, Venus Medtech, Direct Flow Medical, Sorin Group, Blue Sail Medical Co. Ltd., JC Medical Inc., Cook Medical Inc., Sysmetis SA, SMT Pvt Ltd., LivaNova, Peijia Medical, and P+F Products + Features GmbH, and others.
DelveInsight’s “Transcatheter Aortic Valve Replacement (TAVR) Market Forecast 2027” research report provides the current and forecasted transcatheter aortic valve devices market size, share, and trends analysis for the next five years. Moreover, it also the ongoing innovations in the segment, major market drivers & barriers, key competitors, and emerging devices in the domain.
Transcatheter Aortic Valve Replacement Market: Overview
Transcatheter aortic valve replacement (TAVR, alternately known as transcatheter aortic valve implantation [TAVI]) is a minimally invasive procedure wherein the diseased valve is replaced by an artificial, man-made valve. There are several man-made transcatheter aortic valves that are used while performing TAVR procedures. These include SAPIEN 3, SAPIEN 3 Ultra, Evolut PRO+, and LOTUS Edge.
Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure to replace a narrowed aortic valve that fails to open properly (aortic valve stenosis). In this procedure, surgeons insert a catheter into the leg or chest and guide it to the heart.13-Oct-2021
DelveInsight’s “Transcatheter Aortic Valve Replacement (TAVR) Market Report” provides an in-depth assessment of the market, segmented by material (valve frame material (nitinol, stainless steel, cobalt chromium, and others), valve leaflet material (porcine, bovine, and others)], by procedure (transfemoral, transapical and transaortic approach), by application (aortic stenosis, aortic regurgitation, and others), by the end user (hospitals, ambulatory surgical centers, and others), and by geography (North America, Europe, Asia-pacific, and rest of the world).
As per the analysis, in the application segment of the transcatheter aortic valve replacement devices market, the TAVR devices used in the aortic stenosis segment are estimated to hold a significant share during the forecast period. This can be ascribed to the increasing prevalence of aortic stenosis disorder, the approval and launch of TAVR devices indicated for use in aortic stenosis disorder, and the technological advancements in TAVR devices for treating aortic stenosis.
Transcatheter Aortic Valve Replacement (TAVR) Market Analysis
The global transcatheter aortic valve replacement market is anticipated to grow in the coming years for various reasons. The rising prevalence of aortic stenosis disorder is one of the key factors for the rising demand for TAVR devices. As per the data from WHO, in 2020, the prevalence of calcific aortic valve stenosis was found to be 9 million across the world. Moreover, according to the John Muir Health statistics, in the United States, about 1.5 million people tend to suffer from aortic stenosis, and about 500,000 people within this group of patients tend to suffer from severe aortic stenosis (in 2020). Due to the rise in aortic stenosis worldwide, there will be a high demand for trans-catheter valves and TAVR procedures worldwide, thereby driving the TAVR market growth.
Moreover, the rising prevalence of cardiovascular disorders and the technological advancements in developing new devices are other major key factors leading to a higher demand for TAVR devices. However, the stringent regulatory approval process for transcatheter aortic valves and the high costs associated with the TAVR procedures are anticipated to hamper the market growth.
Interested to know more about the ongoing developments in the market? Visit to get an in-depth insight into Transcatheter Aortic Valve Replacement Types and Emerging Products
Transcatheter Aortic Valve Replacement – Global Market Assessment and Forecast
Among all the regions, North America is expected to account for the significant market revenue share in the transcatheter aortic valve replacement devices market during the forecast, owing to the increasing number of aortic stenosis (aortic regurgitation cases) and the rising prevalence of cardiovascular diseases. Moreover, the growth in transcatheter aortic valve replacement device approvals and launches and their expansion in newer indications are anticipated to drive the market growth in the region further. Thus, owing to an increase in the number of approvals for TAVR devices in the United States, there will be an increase in availability and demand for TAVR devices in the US, leading to a growth in the overall market for TAVR devices in the coming years.
Interested in knowing how the market will grow by 2027? Click to get a snapshot of Transcatheter Aortic Valve Replacement Market Trends and Developments
Transcatheter Aortic Valve Replacement Market – Key Developments and Breakthroughs
Over the years, the transcatheter aortic valve replacement market has evolved significantly owing to the active participation of the global MedTech companies and technological advancements in the domain.
Some of the major advancements in the Transcatheter Aortic Valve Replacement Market in recent years are –
- On January 17, 2023, Abbott announced that the U.S. Food and Drug Administration (FDA) had approved the company’s latest-generation transcatheter aortic valve implantation (TAVI) system, Navitor™, to treat people with severe aortic stenosis who are at high or extreme risk for open-heart surgery.
- On September 15, 2022, OpSens Inc. announced that it had received 510(k) regulatory clearance from the U.S. Food & Drug Administration (“FDA”) for the SavvyWire™ (“SavvyWire”), its new guidewire for transcatheter aortic valve replacement procedures, or TAVR.
- On September 20, 2021, Abbott announced that Food and Drug Administration (FDA) had approved the company’s Portico™ with FlexNav™ transcatheter aortic valve replacement (TAVR) system to treat people with symptomatic, severe aortic stenosis who are at high or extreme risk for open-heart surgery.
- On August 24, 2021, Medtronic announced the U.S. Food and Drug Administration (FDA) approval of its newest-generation, self-expanding transcatheter aortic valve replacement (TAVR) system, the Evolut™ FX TAVR system.
- On May 17, 2021, Abbott announced that it had received CE Mark for its latest-generation transcatheter aortic valve implantation (TAVI) system, Navitor™, making the minimally invasive device available for people in Europe with severe aortic stenosis who are at high or extreme surgical risk.
Learn more about the ongoing development in the market @ Transcatheter Aortic Valve Replacement Market – Clinical and Commercial Development Activities
Key Companies in the Transcatheter Aortic Valve Replacement Market
The leading MedTech companies operating in the transcatheter aortic valve replacement devices market include Medtronic, Edwards Lifesciences Corporation, Boston Scientific Corporation, Meril Life Sciences, Abbott, JenaValve Technology, Inc., Bracco SpA, Transcatheter Technologies GmbH, Braile Biomedica, Venus Medtech, Direct Flow Medical, Sorin group, Blue Sail Medical Co. Ltd., JC Medical Inc., Cook Medical Inc., Sysmetis SA, SMT Pvt Ltd., LivaNova, Peijia Medical, and P+F Products + Features GmbH, and others. Due to the very high growth rate and positive return, several new players are expected to enter the Transcatheter Aortic Valve Replacement Market in the coming years.
Learn how new players’ entries will transform the market dynamics in the coming years @
Transcatheter Aortic Valve Replacement Competitive Landscape
Scope of the Transcatheter Aortic Valve Replacement Market Report:
- Study Period – 2019-2027
- Transcatheter Aortic Valve Replacement Market Assessment –
- By Material – Valve Frame Material (Nitinol, Stainless Steel, Cobalt Chromium, and others), Valve Leaflet Material (Porcine, Bovine), and others
- By Procedure – Transfemoral, Transapical, and Transaortic Approach
- By Application – Aortic Stenosis, Aortic Regurgitation, and others
- By End-User – Hospitals, Diagnostic Imaging Centers, and others
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s Views
- Geography Covered – Global – North America, Europe, Asia-Pacific, and Rest of the World
Table of Content
| 1 | Report Introduction |
| 2 | Executive Summary |
| 3 | Regulatory and Patent Analysis |
| 4 | Transcatheter Aortic Valve Replacement Market Key Factors Analysis |
| 5 | Transcatheter Aortic Valve Replacement Porter’s Five Forces Analysis |
| 6 | COVID-19 Impact Analysis on the Transcatheter Aortic Valve Replacement Market |
| 7 | Transcatheter Aortic Valve Replacement Market Layout |
| 8 | Transcatheter Aortic Valve Replacement Global Company Share Analysis – Key 3–5 Companies |
| 9 | Transcatheter Aortic Valve Replacement Product Profiles and Key Companies |
| 10 | Project Approach |
| 11 | KOL Views |
| 12 | DelveInsight Capabilities |
| 13 | Disclaimer |
| 14 | About DelveInsight |
Reach out to us to get a more detailed overview of the market @
Transcatheter Aortic Valve Replacement/Implantation Market Insights and Competitive Landscape
Related Report by DelveInsight
Aortic Stenosis Market Outlook
“Aortic Stenosis Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Aortic Stenosis, historical and forecasted epidemiology as well as the Aortic Stenosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Aortic Stenosis Epidemiology Forecast
“Aortic Stenosis Epidemiology Forecast to 2032” report delivers an in-depth understanding of the disease, historical and forecasted Aortic Stenosis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Transcatheter Heart Valve Replacement Devices Market Outlook
“Transcatheter Heart Valve Replacement Devices Market Insight, Competitive Landscape and Market Forecast, 2027” report delivers an in-depth understanding of the historical and forecasted Transcatheter Heart Valve Replacement Devices market size, share, and trends analysis globally, which comprises North America, Europe, APAC, and RoW.
Transcatheter Mitral Valve Repair Devices Market Outlook
“Transcatheter Mitral Valve Repair Devices Market Insight, Competitive Landscape and Market Forecast, 2027” report delivers an in-depth understanding of the historical and forecasted Transcatheter Mitral Valve Repair Devices market size, share, and trends analysis globally, which comprises North America, Europe, APAC, and RoW.
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Learn How the MedTech Devices Market is evolving with the ongoing clinical and commercial developments in the domain: MedTech Market Outlook
Contact Us
Shruti Thakur
Manager (Marketing & Branding)
info@delveinsight.com
+1(919)321-6187